Follow
Dasom Lee
Dasom Lee
Verified email at ncsu.edu
Title
Cited by
Cited by
Year
Improving trial generalizability using observational studies
D Lee, S Yang, L Dong, X Wang, D Zeng, J Cai
Biometrics, 2021
542021
Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target population
D Lee, S Yang, X Wang
Journal of causal inference 10 (1), 415-440, 2022
21*2022
Transporting survival of an HIV clinical trial to the external target populations
D Lee, C Gao, S Ghosh, S Yang
Journal of Biopharmaceutical Statistics, 1-22, 2024
82024
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
SD Nathan, S Johri, JM Joly, CS King, A Raina, CA McEvoy, D Lee, ...
thorax 79 (4), 301-306, 2024
62024
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily
S Shapiro, S Mandras, R Restrepo-Jaramillo, E Shen, M Broderick, Y Rao, ...
Pulmonary Circulation 11 (4), 20458940211052228, 2021
62021
genRCT: a statistical analysis framework for generalizing RCT findings to real-world population
D Lee, S Yang, M Berry, T Stinchcombe, HJ Cohen, X Wang
Journal of Biopharmaceutical Statistics, 1-20, 2024
32024
Real-world transitions from parenteral, inhaled, and oral prostacyclin-class therapies to oral treprostinil: interim data from the ADAPT registry
S Sahay, A Ravichandran, K Parikh, K Gordon, M Broderick, D Lee, ...
B56. PULMONARY HYPERTENSION CLINICAL TRIALS ENDEAVOR SAFETY, COMBINATION …, 2020
32020
Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
VP Balasubramanian, Z Safdar, MR Sketch, M Broderick, AC Nelsen, ...
Pulmonary Circulation 12 (1), e12016, 2022
22022
Interim data from the ADAPT registry: real-world tolerability and management of adverse events in patients receiving oral treprostinil
J Kingrey, J Swisher, A Ravichandran, J Gordon, K Gordon, M Broderick, ...
Chest 158 (4), A2169-A2170, 2020
22020
DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING
A Waxman, S Nathan, M Fisher, HJ Ford, J Gagermeier, J Parambil, ...
Chest 160 (4), A2279-A2280, 2021
12021
ORAL TREPROSTINIL IMPROVES SURVIVAL IN FREEDOM-EV AND FREEDOM-EV OPEN-LABEL EXTENSION PARTICIPANTS WITH PULMONARY ARTERIAL HYPERTENSION
RJ White, JW McConnell, AB Waxman, A Hage, LM Cadaret, ...
Chest 164 (4), A5873-A5875, 2023
2023
Bayesian Analysis of First-Order Markov Models for Autocorrelated Binary Responses
D Lee, S Ghosh
Journal of Statistical Theory and Practice 17 (1), 9, 2023
2023
Semiparametric Inference of Randomized Controlled Trials and Observational Studies
D Lee
North Carolina State University, 2022
2022
REAL-WORLD PATIENT REPORTED OUTCOMES USING SF-12 AND EMPHASIS-10 IN PATIENTS RECEIVING ORAL TREPROSTINIL: INTERIM ANALYSIS FROM THE ADAPT REGISTRY
S Sahay, A Khan, D Lachant, D Lee, C Park, M Broderick, R Benza
Chest 160 (4), A2290-A2291, 2021
2021
Bayesian ordinal probit semiparametric regression models: KNHANES 2016 data analysis of the relationship between smoking behavior and coffee intake
D Lee, E Lee, S Jo, T Choi
The Korean Journal of Applied Statistics 33 (1), 25-46, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–15